Carlos Fernandez-Hernando, PhD
Anthony N. Brady Professor of Comparative Medicine and of Pathology and Director of Vascular Biology & Therapeutics Program; Director, Vascular Biology and Therapeutics Program
Fernández-Hernando Lab group combines basic biochemical and molecular biology approaches with preclinical and translational studies to unravel fundamental mechanism regulating lipid metabolism and blood vessels in physiological and pathophysiological conditions such as atherosclerosis, obesity, and diabetes. Our studies elucidated the fundamental contribution of non-coding small RNAs (e.g. microRNA-33) in regulating cellular cholesterol and fatty acid metabolism.